News

Lola Fayanju, MD, Assistant Professor of Surgery, Division of Advanced Oncologic and Gastrointestinal Surgery, presented her recent research at the American Surgical Association (ASA) Annual Meeting. Her research involved a review of 20,000 patients in the National Cancer Database, with a focus on the results of neoadjuvant chemotherapy and its link to overall survival rates.

The Duke Department of Surgery is pleased to announce the appointment of Peter J. Allen, MD, as the new Chief of the Division of Surgical Oncology in the Department of Surgery and Chief of Surgery for the Duke Cancer Institute (DCI).

The Society of Surgical Oncology has selected Georgia Beasley, MD, MHS, Assistant Professor of Surgery, to present at the 13th International Symposium on Regional Cancer Therapies.

The Section of Breast Surgery in the Division of Advanced Oncologic and Gastrointestinal Surgery has 5 abstracts accepted for oral or poster presentation at the Society of Surgical Oncology (SSO) Annual Meeting next month in Chicago. The abstracts materialized from the Duke Breast Clinical Outcomes Meeting, a weekly meeting created by Dr.

Five faculty members from the Duke Department of Surgery have been selected to participate in the 2018 Duke Leadership Development for Researchers (LEADER) program sponsored by the Duke University School of Medicine Office of Faculty Development. Duke Surgery’s participants include the following members:

For Rachel A. Greenup, MD, MPH, Assistant Professor, Division of Advanced Oncologic and Gastrointestinal Surgery, understanding how the cost of treatment impacts women with breast cancer is paramount to her research. Dr. Greenup has been selected to present her latest research abstract, “The Financial Burden of Breast Cancer Treatment,” at the annual Office of Research on Women’s Health (ORWH) meeting in October. 

Study finds little survival benefit and high costs from the preventive procedure Mutations in the BRCA gene correspond to a higher lifetime risk of developing breast and ovarian cancers, and many women who carry these mutations consider undergoing mastectomy or removal of the ovaries and fallopian tubes as preventive measures.

Study Provides New Insights Into 3D Imaging and Targeting Tumor Emboli in Patients with Inflammatory Breast Cancer Duke researchers have found that a drug used for alcohol abuse reduces the formation of tumor emboli in inflammatory breast cancer (IBC), one of the most lethal types of breast cancer. Current barriers to the successful treatment of IBC include the presence and frequent infiltration of tumor cell clusters, termed tumor emboli, within the breast parenchyma and lymphatics.

Congratulations to Rachel Greenup, MD, MPH, Division of Advanced Oncologic and Gastrointestinal Surgery, for being selected as a recipient of the Health Policy Scholarship provided by the American College of Surgeons and the American Society of Breast Surgeons.

According to Sanziana Roman, MD, and Julie Ann Sosa, MD, Division of Advanced Oncologic and Gastrointestinal Surgery, thyroid nodules continue to be a common problem worldwide. Though many nodules are benign, anxiety on the part of both the physician and patient can cause unnecessary interventions to take place.